• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA125抗原的糖型作为一种潜在的癌症标志物。

Glycoforms of CA125 antigen as a possible cancer marker.

作者信息

Jankovic Miroslava M, Milutinovic Bojana S

机构信息

Institute for the Application of Nuclear Energy-INEP, University of Belgrade, Banatska 31b, 11080 Zemun, Serbia.

出版信息

Cancer Biomark. 2008;4(1):35-42. doi: 10.3233/cbm-2008-4104.

DOI:10.3233/cbm-2008-4104
PMID:18334732
Abstract

CA125, a coelomic epithelium-related antigen, is expressed in both normal and pathological conditions. In this study, we compared the glycosylation of CA125 antigen from amniotic fluid and the ovarian carcinoma cell line OVCAR-3, in order to detect possible differences as a specific marker of their origin. Antigens from both sources were radiolabelled and subsequently subjected to the affinity chromatography, using plant lectins differing in carbohydrate specificity as ligands. A common chromatographic scheme was applied to all columns, i.e. they were eluted with: a) washing buffer to wash out non-bound and low-affinity bound fractions, b) a solution of inhibitory sugar and c) a low pH buffer, to release the high affinity bound fractions. CA125 antigen from each source was found to be heterogeneous in respect to the existence of multiple glycoforms, with O-linked glycan chains predominating. However, the binding patterns of both N- and O-linked glycan-reactive lectins indicated distinct differences in carbohydrate composition between CA125 antigen isolated from amniotic fluid and OVCAR-3 cell line. The observed specificites of CA125-oligosaccharide chains might be of special importance from the biomedical aspect, in terms of their possible use for clinical evaluation of gynecological functions in health and disease.

摘要

CA125是一种与体腔上皮相关的抗原,在正常和病理条件下均有表达。在本研究中,我们比较了羊水和卵巢癌细胞系OVCAR-3中CA125抗原的糖基化情况,以检测其作为起源特异性标志物的可能差异。对来自两种来源的抗原进行放射性标记,随后使用具有不同碳水化合物特异性的植物凝集素作为配体进行亲和层析。所有柱都采用相同的层析方案,即先用:a) 洗涤缓冲液洗去未结合和低亲和力结合的部分,b) 抑制糖溶液,c) 低pH缓冲液,以释放高亲和力结合的部分。发现来自每种来源的CA125抗原在多种糖型的存在方面具有异质性,其中O-连接聚糖链占主导。然而,N-连接和O-连接聚糖反应性凝集素的结合模式表明,从羊水和OVCAR-3细胞系分离的CA125抗原在碳水化合物组成上存在明显差异。就CA125寡糖链在健康和疾病状态下用于妇科功能临床评估的可能用途而言,所观察到的特异性可能从生物医学角度具有特殊重要性。

相似文献

1
Glycoforms of CA125 antigen as a possible cancer marker.CA125抗原的糖型作为一种潜在的癌症标志物。
Cancer Biomark. 2008;4(1):35-42. doi: 10.3233/cbm-2008-4104.
2
Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen.妊娠相关CA125抗原寡糖链的分子形式与微不均一性
Hum Reprod. 2005 Sep;20(9):2632-8. doi: 10.1093/humrep/dei095. Epub 2005 May 19.
3
Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs).使用唾液酸结合免疫球蛋白样凝集素(Siglecs)评估与癌症和非癌症相关的 CA125 抗原中的唾液酸多样性。
Dis Markers. 2012;32(3):187-94. doi: 10.3233/DMA-2011-0872.
4
Nano-sized CA125 antigen glycocamouflage: Mucin - Extracellular vesicles alliance to watch?纳米级 CA125 抗原糖伪装:粘蛋白-细胞外囊泡联盟值得关注吗?
Arch Biochem Biophys. 2018 Sep 1;653:113-120. doi: 10.1016/j.abb.2018.06.017. Epub 2018 Jun 30.
5
Biochemical and morphological differences between CA125 isolated from healthy women and patients with epithelial ovarian cancer from Tunisian population.来自突尼斯人群的健康女性和上皮性卵巢癌患者中分离的 CA125 的生化和形态差异。
Pathol Oncol Res. 2012 Apr;18(2):325-30. doi: 10.1007/s12253-011-9448-x. Epub 2011 Sep 7.
6
Identification of pregnancy-associated CA125-reactive protein as a carbohydrate-binding immunoglobulin G.鉴定与妊娠相关的 CA125 反应性蛋白为一种碳水化合物结合免疫球蛋白 G。
Arch Biochem Biophys. 2010 Jul;499(1-2):69-76. doi: 10.1016/j.abb.2010.05.011. Epub 2010 May 17.
7
The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.黏蛋白特异性单克隆抗体和凝集素在妇科癌症肿瘤相关血清标志物检测中的应用
Cancer Biochem Biophys. 1993 Sep;13(4):221-38.
8
A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.一种纳米粒子-凝集素免疫测定法可提高血清 CA125 对良恶性来源的区分能力。
Clin Chem. 2016 Oct;62(10):1390-400. doi: 10.1373/clinchem.2016.257691. Epub 2016 Aug 18.
9
Conflicting views on the molecular structure of the cancer antigen CA125/MUC16.对癌症抗原 CA125/MUC16 的分子结构存在不同看法。
Dis Markers. 2010;28(6):385-94. doi: 10.3233/DMA-2010-0719.
10
Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.纳米颗粒辅助的糖变异体分析,以弥合生物标志物性能和 ctDNA 结果之间的差距。
Mol Aspects Med. 2020 Apr;72:100831. doi: 10.1016/j.mam.2019.11.001. Epub 2019 Nov 29.

引用本文的文献

1
Integrins are enriched on aberrantly fucosylated tumour-derived urinary extracellular vesicles.整合素在异常岩藻糖基化的肿瘤来源的尿液细胞外囊泡中富集。
J Extracell Biol. 2022 Oct 10;1(10):e64. doi: 10.1002/jex2.64. eCollection 2022 Oct.
2
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.利用糖组学变化改进基于生物标志物的癌症诊断
Explor Target Antitumor Ther. 2023;4(3):366-395. doi: 10.37349/etat.2023.00140. Epub 2023 Jun 28.
3
Molecular Biomarkers for the Early Detection of Ovarian Cancer.用于卵巢癌早期检测的分子生物标志物。
Int J Mol Sci. 2022 Oct 10;23(19):12041. doi: 10.3390/ijms231912041.
4
High-Throughput Glycomic Methods.高通量糖组学方法。
Chem Rev. 2022 Oct 26;122(20):15865-15913. doi: 10.1021/acs.chemrev.1c01031. Epub 2022 Jul 7.
5
Mucin-Type O-GalNAc Glycosylation in Health and Disease.黏蛋白型 O-糖基化在健康和疾病中的作用。
Adv Exp Med Biol. 2021;1325:25-60. doi: 10.1007/978-3-030-70115-4_2.
6
CA125-Tn ELISA assay improves specificity of pre-operative diagnosis of ovarian cancer among patients with elevated serum CA125 levels.CA125-Tn酶联免疫吸附测定法提高了血清CA125水平升高患者术前卵巢癌诊断的特异性。
Ann Transl Med. 2021 May;9(9):788. doi: 10.21037/atm-20-8053.
7
Insights into Bioinformatic Applications for Glycosylation: Instigating an Awakening towards Applying Glycoinformatic Resources for Cancer Diagnosis and Therapy.糖基化的生物信息学应用洞察:促使人们开始应用糖组学资源进行癌症诊断和治疗。
Int J Mol Sci. 2020 Dec 8;21(24):9336. doi: 10.3390/ijms21249336.
8
Recent advances in mass spectrometry (MS)-based glycoproteomics in complex biological samples.基于质谱(MS)的复杂生物样品糖蛋白质组学的最新进展。
Trends Analyt Chem. 2019 Sep;118:880-892. doi: 10.1016/j.trac.2018.10.009. Epub 2018 Oct 15.
9
MUC16 as a novel target for cancer therapy.MUC16 作为一种新型的癌症治疗靶点。
Expert Opin Ther Targets. 2018 Aug;22(8):675-686. doi: 10.1080/14728222.2018.1498845. Epub 2018 Jul 26.
10
Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer.癌症蛋白质基因组综合分析以鉴定癌症早期诊断和预后的生物标志物
Proteomes. 2017 Oct 25;5(4):28. doi: 10.3390/proteomes5040028.